Search - tctmd.com

Displaying 301 - 320 of 357

Sort: Relevancy | Date

News Conference News ACC 2014

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

April 02, 2014

Presentation PCI Outcomes 2014

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

Presenter: Gregg W. Stone

March 28, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

Presentation CTO 2014

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

Presenter: Gregg W. Stone

March 01, 2014

News Daily News

NCDR Data Show Post-PCI Transfusion Linked with Poor Outcomes

L.A. McKeown

February 26, 2014

News Daily News

Los Datos del NCDE Revelan que las Transfusiones post-PCI acarrean Malos Resultados

L.A. McKeown

February 26, 2014

News Daily News

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

Yael L. Maxwell

February 13, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

Presentation TCT 2013

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Life Is Not So Simple! It Is the Anatomy Not the Diabetes Per Se

Presenter: Gregg Stone

October 29, 2013

Presentation TCT 2013

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

Presenter: Gregg Stone

October 28, 2013

Presentation Fellows 2013

Antithrombin Pharmacology for the Interventionalist

Presenter: Gregg Stone

April 16, 2013

Presentation Fellows 2013

Left Main Disease: PCI vs CABG

Presenter: Gregg Stone

April 15, 2013

News Conference News ACC 2013

Double-Kissing Crush Better than Culotte Technique for Left Main Bifurcation Stenting

Jason Kahn

March 09, 2013

News Conference News ACC 2013

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Yael L. Maxwell

March 09, 2013

Presentation PCI Outcomes 2013

Perspectives on PCI vs. Medical Therapy in Stable Coronary Artery Disease

Presenter: Gregg W. Stone

March 07, 2013

Presentation CTO 2013

How to Improve Left Main PCI Outcomes Today: What Every Operator Must Know!

Presenter: Gregg Stone

February 22, 2013

Presentation TCT 2012

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

The EXCEL Trial: Novel Aspects and Status Update

Presenter: Gregg Stone

October 22, 2012

Presentation

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

Presenter: 62744|Gregg Stone

September 18, 2012

Advertisement

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

EXCEL and NOBLE: Where do Left Main Trials Stand in the Shadows of SYNTAX and FREEDOM?

NCDR Data Show Post-PCI Transfusion Linked with Poor Outcomes

Los Datos del NCDE Revelan que las Transfusiones post-PCI acarrean Malos Resultados

Un Panel de la FDA Rechaza el Cangrelor para las Indicaciones PCI y Terapia Puente

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

The Great Debate: Should Diabetes Modulate the PCI vs CABG Equation? Life Is Not So Simple! It Is the Anatomy Not the Diabetes Per Se

The Final Word in Left Main Stenting? Novel Aspects and Status Update of the EXCEL Trial

Antithrombin Pharmacology for the Interventionalist

Left Main Disease: PCI vs CABG

Double-Kissing Crush Better than Culotte Technique for Left Main Bifurcation Stenting

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Perspectives on PCI vs. Medical Therapy in Stable Coronary Artery Disease

How to Improve Left Main PCI Outcomes Today: What Every Operator Must Know!

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

The EXCEL Trial: Novel Aspects and Status Update

Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content